DNMT1 and breast cancer: Meeran et al. [102] reported that treatment of breast cancer cells (MCF-7 and MDA-MB-231) with sulforaphane causes demethylation of the hTERT promoter via DNMT inhibition, thereby facilitating the binding of CTCF to the promoter site and attenuating hTERT expression and telomerase activity.